269 related articles for article (PubMed ID: 31129415)
1. Illegal cannabis use is common among Danes with multiple sclerosis.
Gustavsen S; Søndergaard HB; Andresen SR; Magyari M; Sørensen PS; Sellebjerg F; Oturai AB
Mult Scler Relat Disord; 2019 Aug; 33():5-12. PubMed ID: 31129415
[TBL] [Abstract][Full Text] [Related]
2. Cannabis use for symptom relief in multiple sclerosis: A cross-sectional survey of webinar attendees in the US and Canada.
Hildebrand A; Minnier J; Cameron MH
Mult Scler Relat Disord; 2020 Feb; 38():101516. PubMed ID: 31855842
[TBL] [Abstract][Full Text] [Related]
3. Medical cannabis use in Canadians with multiple sclerosis.
Santarossa TM; So R; Smyth DP; Gustavsen DS; Tsuyuki DRT
Mult Scler Relat Disord; 2022 Mar; 59():103638. PubMed ID: 35382939
[TBL] [Abstract][Full Text] [Related]
4. Exploring cannabis use by patients with multiple sclerosis in a state where cannabis is legal.
Weinkle L; Domen CH; Shelton I; Sillau S; Nair K; Alvarez E
Mult Scler Relat Disord; 2019 Jan; 27():383-390. PubMed ID: 30502644
[TBL] [Abstract][Full Text] [Related]
5. Cannabis use in people with Parkinson's disease and Multiple Sclerosis: A web-based investigation.
Kindred JH; Li K; Ketelhut NB; Proessl F; Fling BW; Honce JM; Shaffer WR; Rudroff T
Complement Ther Med; 2017 Aug; 33():99-104. PubMed ID: 28735833
[TBL] [Abstract][Full Text] [Related]
6. Cannabis use in persons with traumatic spinal cord injury in Denmark.
Andresen SR; Biering-Sørensen F; Hagen EM; Nielsen JF; Bach FW; Finnerup NB
J Rehabil Med; 2017 Jan; 49(2):152-160. PubMed ID: 28101559
[TBL] [Abstract][Full Text] [Related]
7. Cannabis use in Spanish patients with multiple sclerosis: fulfilment of patients' expectations?
Martínez-Rodríguez JE; Munteis E; Carreño M; Blanco Y; Roquer J; Abanades S; Graus F; Saiz A
J Neurol Sci; 2008 Oct; 273(1-2):103-7. PubMed ID: 18691726
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoids for Treatment of MS Symptoms: State of the Evidence.
Rice J; Cameron M
Curr Neurol Neurosci Rep; 2018 Jun; 18(8):50. PubMed ID: 29923025
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and correlates of non-medical only compared to self-defined medical and non-medical cannabis use, Canada, 2015.
Rotermann M; Pagé MM
Health Rep; 2018 Jul; 29(7):3-13. PubMed ID: 30020531
[TBL] [Abstract][Full Text] [Related]
10. [Systematic review of safeness and therapeutic efficacy of cannabis in patients with multiple sclerosis, neuropathic pain, and in oncological patients treated with chemotherapy].
Amato L; Minozzi S; Mitrova Z; Parmelli E; Saulle R; Cruciani F; Vecchi S; Davoli M
Epidemiol Prev; 2017; 41(5-6):279-293. PubMed ID: 29119763
[TBL] [Abstract][Full Text] [Related]
11. Cannabis use among patients at a comprehensive cancer center in a state with legalized medicinal and recreational use.
Pergam SA; Woodfield MC; Lee CM; Cheng GS; Baker KK; Marquis SR; Fann JR
Cancer; 2017 Nov; 123(22):4488-4497. PubMed ID: 28944449
[TBL] [Abstract][Full Text] [Related]
12. A cross-sectional survey of cannabis use by people with MS in Oregon and Southwest Washington.
Rice J; Hildebrand A; Spain R; Senders A; Silbermann E; Wooliscroft L; Yadav V; Bourdette D; Cameron M
Mult Scler Relat Disord; 2021 Oct; 55():103172. PubMed ID: 34332457
[TBL] [Abstract][Full Text] [Related]
13. Medical marijuana patient counseling points for health care professionals based on trends in the medical uses, efficacy, and adverse effects of cannabis-based pharmaceutical drugs.
Parmar JR; Forrest BD; Freeman RA
Res Social Adm Pharm; 2016; 12(4):638-54. PubMed ID: 26443472
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of low-dose medical cannabis oils in multiple sclerosis.
S G; Hb S; K L; R T; Bs R; Ps S; F S; Ab O
Mult Scler Relat Disord; 2021 Feb; 48():102708. PubMed ID: 33387864
[TBL] [Abstract][Full Text] [Related]
15. Medical cannabis use in the Australian community following introduction of legal access: the 2018-2019 Online Cross-Sectional Cannabis as Medicine Survey (CAMS-18).
Lintzeris N; Mills L; Suraev A; Bravo M; Arkell T; Arnold JC; Benson MJ; McGregor IS
Harm Reduct J; 2020 Jun; 17(1):37. PubMed ID: 32513180
[TBL] [Abstract][Full Text] [Related]
16. Cannabis use in patients with multiple sclerosis.
Chong MS; Wolff K; Wise K; Tanton C; Winstock A; Silber E
Mult Scler; 2006 Oct; 12(5):646-51. PubMed ID: 17086912
[TBL] [Abstract][Full Text] [Related]
17. Perceived support for medical cannabis use among approved medical cannabis users in Canada.
Leos-Toro C; Shiplo S; Hammond D
Drug Alcohol Rev; 2018 Jul; 37(5):627-636. PubMed ID: 29873132
[TBL] [Abstract][Full Text] [Related]
18. Cannabis and multiple sclerosis.
Fragoso YD; Carra A; Macias MA
Expert Rev Neurother; 2020 Aug; 20(8):849-854. PubMed ID: 32515670
[TBL] [Abstract][Full Text] [Related]
19. Attitudes to cannabis and patterns of use among Canadians with multiple sclerosis.
Banwell E; Pavisian B; Lee L; Feinstein A
Mult Scler Relat Disord; 2016 Nov; 10():123-126. PubMed ID: 27919478
[TBL] [Abstract][Full Text] [Related]
20. The impact of legalization of access to recreational Cannabis on Canadian medical users with Cancer.
Hawley P; Gobbo M; Afghari N
BMC Health Serv Res; 2020 Oct; 20(1):977. PubMed ID: 33109169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
